Posted in | News | Nanomedicine

Scientists Develop Nano-Sized Form of Aspirin

Scientists are reporting development of a new form of aspirin — taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke — that could extend aspirin’s benefits to people who may not respond to the drug. Their advance toward coping with “aspirin resistance” appears in the journal ACS Nano.

Shiqi Peng, Ming Zhao and colleagues note that aspirin lowers cardiovascular disease risk by keeping blood cells called platelets from clumping and forming clots. But some experts believe that aspirin doesn’t work for millions of people, who may switch to more costly, potent prescription drugs with more serious side effects. Scientists have tried to address aspirin resistance by combining it with other drugs. But Peng and Zhao say that the problem remains. Their research group decided to modify aspirin in an effort to make it work for more people.

They linked aspirin to a carrier consisting of a fragment of protein that can transport aspirin directly to damaged parts of blood vessels where clots form. Experiments with laboratory rats, stand-ins for humans in such early tests, showed that the carrier delivered aspirin to areas of blood vessels where clots were forming. It released aspirin inside the developing clot and stopped the clot-formation process.

The authors acknowledge funding from the Engineering Research Center of Endogenous Prophylactic of the Ministry of Education of the People’s Republic of China, PHR (IHLB), the National Natural Science Foundation and the Beijing Natural Science Foundation and Special Project of China.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    American Chemical Society. (2019, February 11). Scientists Develop Nano-Sized Form of Aspirin. AZoNano. Retrieved on May 25, 2024 from

  • MLA

    American Chemical Society. "Scientists Develop Nano-Sized Form of Aspirin". AZoNano. 25 May 2024. <>.

  • Chicago

    American Chemical Society. "Scientists Develop Nano-Sized Form of Aspirin". AZoNano. (accessed May 25, 2024).

  • Harvard

    American Chemical Society. 2019. Scientists Develop Nano-Sized Form of Aspirin. AZoNano, viewed 25 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.